Ablative Solutions Completes Enrollment in Pivotal Trial of Peregrine Renal Denervation System
April 12, 2023—Ablative Solutions, Inc. announced the completion of patient enrollment in the TARGET BP I study, which is evaluating alcohol-med
United States David Kandzari Piedmont Heart Institute In Atlanta Ablative Solutions Inc Ablative Solutions Coprincipal Investigator David Kandzari
Source: evtoday.com